DF
BMY icon

Dunhill Financial’s Bristol-Myers Squibb BMY Stock Holding History

Dunhill Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Buy
1,891
+1,824
+2,722% +$106K 0.03% 204
2025
Q4 		$3.63K Buy
67
+19
+40% +$914 ﹤0.01% 636
2025
Q3 		$2.16K Sell
48
-397
-89% -$18.5K ﹤0.01% 688
2025
Q2 		$20.6K Sell
445
-7
-2% -$344 0.01% 330
2025
Q1 		$27.6K Buy
452
+61
+16% +$3.56K 0.01% 255
2024
Q4 		$22.1K Sell
391
-273
-41% -$15.3K 0.01% 269
2024
Q3 		$34.4K Buy
664
+189
+40% +$8.87K 0.02% 202
2024
Q2 		$19.7K Buy
475
+229
+93% +$10.2K 0.01% 216
2024
Q1 		$13.3K Buy
246
+29
+13% +$1.48K 0.01% 199
2023
Q4 		$11.2K Buy
+217
New +$11.4K 0.01% 196

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dunhill Financial's BMY Position: Q1 2026 in Review

Dunhill Financial increased its Bristol-Myers Squibb (BMY) stake by 2,722% in Q1 2026, buying an estimated $106K and bringing the position to 1,891 shares worth $115K. The position accounts for 0.03% of the portfolio, ranked #204.

Dunhill Financial first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Dunhill Financial held 1,891 shares of Bristol-Myers Squibb worth $115K as of Q1 2026.
  • Dunhill Financial bought 1,824 Bristol-Myers Squibb shares in Q1 2026, an estimated $106K.
  • Bristol-Myers Squibb made up 0.03% of Dunhill Financial's portfolio in Q1 2026, its #204 holding.
  • Dunhill Financial first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.